您的位置: 首页 > 农业专利 > 详情页

NOUVEAU COMPOSÉ ET SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI
专利权人:
Meiji Seika Pharma Co.; Ltd.
发明人:
ARAI Mami,YAMAKAWA Takeru,NAKAJIMA Rie,MURASAKI Kota,WAKIYAMA Yoshinari,FUJIWARA Yuta,ISHIKAWA Makoto,NINOMIYA Tomohisa
申请号:
EP17744401
公开号:
EP3409662A4
申请日:
2017.01.27
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
A compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof: [in the formula (I), A 1 represents a methylene group or the like; A 2 represents a methylene group or an oxygen atom; A 3 represents an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, a piperazinyl group, or a homopiperazinyl group which is optionally substituted with -N(R 1 )R 2 , -N(R 1 )R 3 , and/or -R 3 ; A 4 represents -O-, -S-, -S(O)-, -S(O) 2 -, or -N(R 1 )-; A 5 represents an optionally substituted C 3-10 cycloalkylalkyl group or the like; R 4 represents a halogen atom or the like; and n represents an integer of 0 or 1].
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充